Reduction of major adverse and major cardiovascular events in patients with atrial fibrillation and stent implantation treated with left atrial occlusion device vs oral anticoagulants strategy.
26 August 2022 (12:15 - 13:00)
Organised by:
Abstract
Slides
About the speaker
University Hospital of Badajoz, Badajoz (Spain)
6 More presentations in this session
Doctor W. Koh (New York, US)
Doctor R. Eikelboom (Hamilton, CA)
Access the full session
The Event
ESC Congress 2022
26 August 2022
12:15 CET
You may be interested in
Congress Presentation
